04/14/2014 | Mark Hillen
What does analysis of the last five years of literature on diabetic macular edema tell us about the priorities of the field and the major contributors to it?
04/13/2014 | Mark Hillen
Subcutaneously-administrated IL-18 works well to reverse choroidal neovascularization (in mice).
04/13/2014 | Isabelle Leach
Evidence is stacking up that the configuration of the VMI alters the functional and anatomic efficacy of anti-VEGF drugs.
03/10/2014 | Stela Vujosevic
Advances in understanding of the therapeutic mechanisms that underpin micropulse laser treatment suggest that protocols for treatment of diabetic macular edema should be integrated.
03/10/2014 | Mark Hillen
Although baby boomers may be in a state of denial regarding their own aging, ophthalmologists know differently. In particular, four diseases of the ageing eye comprise a demographic and economic timebomb.
Previous studies linked aspirin use with age-related macular degeneration, but new data suggest otherwise: aspirin is innocent of all charges.
If you’re aged over 68 years, then statins significantly reduce your risk of developing AMD; it has no impact on younger age groups.
Mice that take exercise exhibit slower retinal degeneration than those that don’t. It could work for people too.
02/11/2014 | Mark Hillen
Can you envisage a future in which deploying a tiny cell-spraying device during vitreoretinal surgery reverses years of retinal cell death? Keith Martin can.
02/11/2014
Sitting Down With Walter Wrobel, CEO/ President, and Reinhard Rubow, CFO, Retina Implant AG
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: